Abstract: PURPOSE: To provide evidence for the endovascular repair of patients with extracranial carotid artery dissection. MATERIALS AND METHODS: A comprehensive literature review was performed whereby all studies that reported on the results of endoluminal repair of extracranial carotid artery dissection and provided information about primary technical and clinical success were identified. The Pubmed, Embase, and Medline databases were searched between January 1997 and February 2008 by two independent observers by using combinations of search terms "endovascular repair," "extracranial carotid artery," and "carotid dissection." RESULTS: After studies were selected according to the given criteria, 13 studies were included in our statistical analysis. The number of reported patients was 62, with a total of 63 extracranial carotid artery dissections. The mean patient age was 43.3 years. The mean follow-up period was 15.7 months +/-8.7. Various causes were responsible for the disease, including a blunt neck injury in 28 patients (45%), spontaneous dissection in 21 (37%), and iatrogenic trauma during invasive radiologic procedure in 17.7% patients. The technical success rate was 100% (63 of 63 procedures). The primary and 1-year patency rate of the stents and/or stent-grafts was 100%. The overall major adverse cardiovascular events rate was 11% (seven strokes). The total follow-up mortality rate was 0%. CONCLUSIONS: The current status of the reported cases in the literature regarding the treatment of carotid artery dissection by means of stent placement shows excellent early and 1-year patency rates and a low major adverse cardiovascular event rate. However, further evaluation is necessary to draw robust conclusions.
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THE first case of spontaneous dissection of the carotid artery was described by Jentzer (1) in 1954. The average incidence rate is 2.6 -3.0 per 100,000 population (2), and it is an important cause of stroke in young adults (3). The actual incidence may be higher because many cases are asymptomatic or show only minor transient neurologic symptoms and remain undiagnosed.
The main mechanism of ischemic stroke in carotid artery dissection is thromboembolism (4) . Consistent with these findings, antithrombotic treatment with anticoagulatives or aspirin and frequent control of the diseased artery with imaging remains the first-line treatment option (4) . Nevertheless, several medical conditions-such as the recurrence of neurologic deficits despite appropriate antithrombotic therapy, hemodynamic brain ischemia, contraindication of antiplatelet medication because of the risk of bleeding, and the expansion of concomitant pseudoaneurysms with neurologic symptomatology-justify an alternative therapeutic approach to achieve a sufficient restoration of the vessel lumen.
Because of the unfavorable results of surgery (5) , which are linked to substantial difficulties in preparation of the dissected carotid artery and cranial nerve injury, endovascular strategies are increasingly applied, with corresponding reported outcomes encouraging (6 -18) .
We performed a literature review and analysis to determine the outcome and safety of endovascular repair of acute extracranial carotid artery dissection.
MATERIALS AND METHODS
Search Strategy
An extensive search of literature published between January 1997 and 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56 1 tapraid4/jvi-jvir/jvi-jvir/jvi99908/jvi2595d08z moyerr Sϭ1 9/16/08 17:22 Art: 761 databases with keywords "endovascular repair," "extracranial carotid artery," and "carotid dissection." In addition, reference lists of all included articles were examined for further relevant references. All studies were independently assessed by two reviewers for inclusion and exclusion criteria, and the full text of these studies was retrieved.
Eligibility of the Studies
Studies were included if the following criteria were fulfilled: (a) endoluminal repair of the carotid artery dissection was the intended repair strategy, (b) there had been a minimum follow-up period of 6 months, and (c) the diagnosis of extracranial carotid artery dissection and brain ischemia had been performed with contrast medium-enhanced computed tomography (CT), magnetic resonance (MR) imaging, or angiography. The diagnosis of carotid artery dissection was based on the detection of a mural hematoma in the cervical carotid artery. Angiographic diagnosis was based on detection of a flame-shaped occlusion, string sign, segmental stenosis beginning distal to the carotid bulb, or a dissecting aneurysm. In addition, in the presence of occlusion of the cervical carotid artery at angiography, studies were included if MR imaging detection of a mural hematoma was needed for the diagnosis of carotid artery dissection, (d) at least one of the basic outcome criteria (ie, neurologic morbidity, stent patency, endoprosthesis-related complications, and total mortality rate) was stated, (e) endoluminal repair of the carotid dissection performed during intraarterial thrombolysis was excluded, and (f) no cases involved the intracranial carotid artery either exclusively or by extension.
Data Extraction and Analysis
For each study, the following data were extracted and analyzed by two independent reviewers: the number of patients and their sex and mean age (in years); initial symptoms at clinical examination; primary technical success; 30-day clinical success; stentgraft design; mean follow-up period (in months); neurologic morbidity; major adverse cardiovascular events, including myocardial infarction, stroke, and death; stent and/or stent-graft patency and endoprosthesis-related complications; repeat interventions; and total follow-up mortality. Fulfilment of all of these particular parameters was an obligatory condition of the inclusion of the particular patient group in the meta-analysis. In cases of divergent data extraction results between the two observers, articles were reviewed again and data extracted in consensus. The clinical success of the technique was defined as technical success and as clinical success was defined in the absence of transient ischemic attacks, local symptoms and signs and ischemic events occurring within 30 days after the intervention other adverse events (eg, inguinal bleeding, aneurysms, bleeding with anemia).
Patient Selection Criteria
Patients with acute carotid artery dissection treated with stent and/or stentgraft-supported angioplasty were selected on the basis of (a) the failure of conservative treatment and drug administration with persistent neurologic deficits; (b) ischemic or thromboembolic symptoms; (c) contraindication to anticoagulation and antiplatelet therapy due to the presence of a large infarct with associated mass effect, hemorrhagic transformation of the infarcted area, and an intracranial aneurysm; (d) traumatic dissections with high-degree stenosis; (e) expansion of concomitant pseudoaneurysms in the extracranial carotid artery with neurologic deficits; (f) severe reduction in cerebral blood flow; and (g) contraindication of open repair in the patients.
Distribution of the Studies according to Specialty
The included studies were published from different clinical departments such as the division of vascular surgery (n ϭ 3), neurosurgery (n ϭ 3), general surgery (n ϭ 2), interventional radiology (n ϭ 2), and neurology (n ϭ 1). The inhomogeneous medical background is demonstrated in the characterization of the postoperative neurologic events. To overcome this medical impasse, central neurologic symptoms were defined as amaurosis fugax, transient ischemic attack, and stroke and local neurologic symptoms and signs were defined as unilateral headache, Horner syndrome, or palsy of cranial nerves.
Statistical Analysis
All numeric values are stated as means Ϯ standard deviations, with minimum and maximum values in parentheses. All percentages were calculated by using the total number of reported patients as 100% for each parameter.
RESULTS
Our electronic literature search resulted in 27 studies. After additional search by hand and selection in accordance with the inclusion criteria, 13 studies were included in our statistical analysis (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . Detailed data from the eligible studies are provided in Table  1 , and data from the excluded articles (5,19 -31) are given in Table 2 . Studies were excluded if there was conservative or surgical treatment of acute carotid dissection, involvement of the intracranial segment of the carotid artery or vertebral artery, follow-up of less than 6 months, and no report of clinical outcomes.
The eligible studies included 62 patients, 34 of whom were men (55%). The mean patient age was 43.3 years Ϯ 8.7 (range, 17-80 years; median, 45.3 years). In 39 of the 62 patients (63%), the presumed cause of the carotid dissection was trauma; in 11 of those patients (18%), iatrogenic dissection occurred during an invasive radiologic procedure. In the remaining 23 patients (37%), dissections showed spontaneous development. The mean follow-up period was 15.7 months Ϯ 8.7 (range, 5.6 -38.3 months; median, 13.5 months).
The presenting characteristics for the patients with symptomatic carotid dissection are shown in Table 3 . The technical success rate was 100% (63 of 63 procedures). The primary and 1-year patency rate of the stent and/or stent-grafts was 100%. During the follow-up period, one asymptomatic instent de novo restenosis (1.5%) of the dissected carotid was noted 22 months after the initial successful intervention. This was treated conservatively, and the patient remained without neurologic deficits. Furthermore, 54 of the 62 patients (87%) remained free of new or 57  58  59  60  61  62  63  64  65  66  67  68  69  70  71  72  73  74  75  76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91  92  93  94  95  96  97  98  99  100  101  102  103  104  105  106  107  108  109  110  111  112  113  114  115  116  117 tapraid4/jvi-jvir/jvi-jvir/jvi99908/jvi2595d08z moyerr Sϭ1 9/16/08 17:22 Art: 761 recurrent ischemic symptoms after the endovascular approach. Seven of the 62 patients (11%) experienced an early (Ͻ30 days) central neurologic event, including an ischemic stroke in six patients (9.7%) and a transient ischemic attack in one patient (1.6%). Subsequent clinical symptoms such as hemiparesis (n ϭ 2), persistent dysphagia (n ϭ 1), residual hand weakness (n ϭ 1), hemorrhagic conversion with recovery (n ϭ 1), and partial expressive aphasia (n ϭ 1) occurred due to the cerebral infarction. Another patient had a stroke in the territory contralateral to the carotid occlusion after hypotensive uterine hemorrhage occurred 8 months after endovascular repair of the carotid dissection.
No disease-related death was noted in the included patients after the primary successful endovascular intervention. Thus, the early (Ͻ30 days) postprocedural major cardiovascular events rate was 9.7% (six strokes). The overall postprocedural major cardiovascular events rate was 11% (seven strokes). No patient experienced myocardial infarction, contrast medium-induced renal insufficiency, or a minor complication such as relevant groin hematoma.
Patient demographics and results are shown in Table 4 . Four of the 13 included studies report on a spontaneous cause of the dissection. Five studies describe the outcome of the endovascular strategies in carotid dissection only of traumatic origin. The other articles analyze mixed cases of spontaneous and traumatic cause without separating the outcomes for the spontaneous and traumatic cases. Therefore, it was not possi- (4) 48 X Bassi et al (22) 49 X Dziewas et al (23) 126 X X Townend et al (24) 2 X Lee and Jensen (25) 1 X X X Chiche et al (26) 10 Sagoh et al (27) 1 X Chaves et al (28) 10 X Pace et al (29) 2 X Mas et al (30) 13 X Lin et al (31) 5 X
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The most commonly used stent and/or stent-graft designs are shown in the Figure. 
DISCUSSION
The treatment of extracranial carotid artery dissection with anticoagulation has been proved to be effective, with an approximate 50%-70% arterial recanalization rate and a 10% risk of late neurologic deficits (32) (33) (34) (35) (36) (37) (38) (39) . However, the high incidence of stroke within 30 days of the dissection (21%-41%) and the approximately 20% mortality rate make a compelling argument for alternative, more successful treatment strategies for overcoming these medical impasses (37) .
Surgical repair of this clinical entity often requires extensive and difficult exposure until the base of the skull which is linked to a 68 % perioperative recurrent stroke rate and cranial nerve injury, and to fracture of the styloid at its base (5). Surgery was performed in patients who had not responded to anticoagulant therapy or those who had developed an aneurysm formation at the distal end of the dissection near the skull base (5). In fact, some authors reported the aneurysm dilatation combined with a proximal highgrade stenosis of at least 80% (5).
Conversely, endoluminal repair of carotid dissection would seem a valuable treatment option in overcoming the several drawbacks of the other two therapy options, that is, anticoagulation and surgery (18) . Additional advantages of endovascular strategies in diagnosis and therapy enable reliable identification of true and false lumens and allow a sufficient restoration of the vessel lumen with use of microcatheter techniques (12) . Moreover, the endovascular approach, also using coil embolization, has proved effective for the simultaneous treatment of any coexistent pseudoaneurysmal dilatations while circumventing the need for cross-clamping, which would not have been tolerated in most patients with poor collateral, contralateral significant involvement, and serious concomitant diseases (10) .
In addition, another benefit of stent-assisted angioplasty is avoidance of the need for shunt implantation, which is also associated with a high risk of extension of the dissection with consecutive neurologic events (18) .
The literature, however, provides scant information with regard to the immediate and long-term results of endovascular repair of carotid dissection, mostly in the form of case reports and small patient series. Therefore, this literature analysis aims to demonstrate the results of the published series under inclusion criteria and attempts to draw several conclusions about the endovascular outcomes.
The use of endovascular techniques in the eligible studies led to a complete neurologic recovery or the absence of new ischemic complications in 54 of the 62 patients (87%). The technical success rate was 100% (63 of 63 procedures). The long-term mortality rate was 0% and the patency rate 100%, with only one asymptomatic in-stent de novo restenosis, which was treated conservatively. In particular, the subgroup analysis of the patients with symptomatic spontaneous carotid dissections showed excellent midterm results (2 years), with no evidence of postinterventional neurologic events and a 100% patency rate. Of the 22 patients with traumatic dissections, two (9%) experienced postprocedural neurologic deficits (two strokes) and one had asymptomatic high-grade stenosis of the internal carotid artery.
In summary, seven patients (11%) experienced an early postprocedural neurologic event (Ͻ30 days). A total of eight patients (13%) had a postprocedural neurologic event (seven patients had stroke, one patient had a transient ischemic attack). Narrowing of the carotid artery caused by dissection seems to be an important potential embolic source. Therefore, deployment of cerebral protection devices during the intervention and extended radiologic imaging appear to be reasonable recommendations for achieving a lower neurologic morbidity over a longer follow-up period. However, most of the reported studies (11 of 13) did not confront the dilemma of cerebral protection device use during the intervention to prevent neurologic deficits.
The adjunctive use of anticoagulative or antiplatelet therapy after the placement of the stent devices seems to be beneficial for preventing thrombus formation on the metal surface of the endograft before endothelialization. The suggested medication is the combination of aspirin (100 mg per day) and Clopidogrel (75 mg per day for 4 -6 weeks after the procedure and then administration of only aspirin [100 mg per day] for life) (18) .
The present review analysis, however, has some clear limitationssuch as an inhomogeneity of the published cases conducted by different medical specialities (eg, vascular surgeons, neurosurgeons, interventional radiologists, and neurologists). This divergence is clearly demonstrated in the description of postoperatively occurring neurologic events, and, despite our clear definitions, definitive conclusions about 181  182  183  184  185  186  187  188  189  190  191  192  193  194  195  196  197  198  199  200  201  202  203  204  205  206  207  208  209  210  211  212  213  214  215  216  217  218  219  220  221  222  223  224  225  226  227  228  229  230  231  232  233  234  235  236  237  238  239  240  241 Moreover, it may be important to estimate the neurologic clinical status of the patients in information about the severity of the stroke by using the Rankin scale scores. This is an important parameter considering that the 9.7% postprocedural stroke rate is high for complications and surpasses that occurring with antithrombotic treatment. Finally, it is important to mention possible bias when reporting novel techniques, tending to overestimate the benefits of that technique when considered in aggregate.
In conclusion, the findings of the present review analysis using stentor stent-graft-supported angioplasty in patients with extracranial carotid artery dissection and failure of other treatment modalities are promising. Nevertheless, further evaluation with a large number of patients and long follow-up is necessary to provide evidence and draw robust conclusions. 
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